Overview

A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Proportion to Roadmap Concept in Patients With HBV Associated-HCC

Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
An open study to evaluate the Efficacy, Safety of Clevudine monotherapy or Adefovir and Clevudine combination in Proportion to Roadmap Concept in patients with chronic hepatitis B Associated Hepatocellular Carcinoma
Phase:
Phase 4
Details
Lead Sponsor:
Bukwang Pharmaceutical
Treatments:
Adefovir
Adefovir dipivoxil
Clevudine